SCHEMBL3498052

SCHEMBL3498052

CCOC(=O)C1(N)Cc2ccc(-c3ccsc3)cc2C1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHEK2 O96017 1/20 0.44
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
USP2 O75604 1/20 0.41
MAPT P10636 1/20 0.41
ALOX15 P16050 1/20 0.41
HSD17B10 Q99714 1/20 0.41
CDC7 O00311 1/20 0.40
DBF4 Q9UBU7 1/20 0.40
HRH2 P25021 1/20 0.40
HRH1 P35367 1/20 0.40
ACMSD Q8TDX5 1/20 0.39
OPRM1 P35372 1/20 0.39
OPRD1 P41143 1/20 0.39
OPRK1 P41145 1/20 0.39
P2RX3 P56373 2/20 0.37
GRIA2 P42262 1/20 0.37
ERN1 O75460 1/20 0.36
ADORA2B P29275 3/20 0.36
POLB P06746 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3498275 0.84 OPRM1 (0.41) HSD17B10OPRM1OPRD1OPRK1ALDH1A1
SCHEMBL3498220 0.81 MEN1 (0.45) MEN1KMT2AMAPTOPRM1POLB
SCHEMBL3499676 0.81 OPRM1 (0.43) MEN1KMT2AMAPTOPRM1ALDH1A1
Hydrochloric Acid SCHEMBL3498072 0.81 OPRM1 (0.45) MEN1KMT2AMAPTOPRM1POLB
SCHEMBL3499699 0.80 AOC3 (0.42) MEN1KMT2AMAPTHSD17B10ALDH1A1
Hydrochloric Acid SCHEMBL3498150 0.78 GRIA1 (0.41) MEN1KMT2AMAPTALOX15HSD17B10
SCHEMBL18664545 0.78 OPRM1 (0.42) MEN1KMT2AMAPTALOX15HSD17B10
SCHEMBL3499819 0.78 TDP2 (0.44) MEN1KMT2AOPRM1
SCHEMBL3498330 0.77 POLB (0.44) HRH2HRH1POLBGSK3B
SCHEMBL1561646 0.76 MEN1 (0.38) MEN1KMT2AOPRM1OPRD1OPRK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100130737-A1 Regulating Agent of GPR34 Receptor Function TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2010-05-27 US disclosed
US-20100130737-A1 Regulating Agent of GPR34 Receptor Function TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2010-05-27 US disclosed
US-20100130737-A1 Regulating Agent of GPR34 Receptor Function TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2010-05-27 US disclosed
EP-1849465-A1 AGENT FOR CONTROLLING FUNCTION OF GPR34 RECEPTOR Takeda Pharmaceutical Company Limited (JP) 2007-10-31 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100130737-A1 Regulating Agent of GPR34 Receptor Function GPR34, GPR4, GPR6 CHEK2 2520/4885MEN1 3918/4885KMT2A 2910/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.